Alternative extrusion–spheronization aids

References

• Vervaet C, Baert L, Remon JP. (1995). Extrusion–spheronization: A literature review. Int J Pharm, 116:131–46.
   Web of Science ®Google Scholar
• Gandhi R, Kaul CL, Panchagnula R. (1999). Extrusion and spheronization in the development of oral controlled release dosage form. Pharm Sci Technol Today, 2(4):160–9.
   Google Scholar
• Law M, Deasy P. (1998). Use of hydrophilic polymers with microcrystalline cellulose to improve extrusion–spheronization. Eur J Pharm Biopharm, 45:57–65.
   PubMed Web of Science ®Google Scholar
• Kleinebudde P. (1994). Shrinking and swelling properties of pellets containing microcrystalline cellulose and low substituted hydroxypropylcellulose: II. Swelling properties. Int J Pharm, 109:221–7.
   Web of Science ®Google Scholar
• Schroder M, Kleinebudde P. (1995). Development of disintegrating pellets obtained from extrusion/spheronization. Pharm Sci, 1:415–18.
   Google Scholar
• Okada S, Nakahara H, Isaka H. (1987). Adsorption of drugs on microcrystalline cellulose suspended in aqueous solutions. Chem Pharm Bull, 35:761–8.
   Web of Science ®Google Scholar
• Basit AW, Newton JM, Lecey LF. (1999). Formulation of ranitidine pellets by extrusion/spheronization with a little and with no microcrystalline cellulose. Pharm Dev Technol, 4:499–505.
   PubMed Web of Science ®Google Scholar
• Liew CV, Josephine LG, Soh LP, Heng PW. (2005). Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: A promising alternative to microcrystalline cellulose. Pharm Res, 22:1387–98.
   PubMed Web of Science ®Google Scholar
• International specialty products, Technical profile: Crospovidone.
   Google Scholar
• Gordon MS, Chowhan ZT. (1987). Effect of tablet solubility and hygroscopicity on disintegrant efficiency in direct compression tablets in terms of dissolution. J Pharm Sci, 76:907–9.
   PubMed Web of Science ®Google Scholar
• Gordon MS, Rudraraju VS, Dani K, Chowhan ZT. (1993). Effect of the mode of super disintegrant incorporation on dissolution in wet granulated tablets. J Pharm Sci, 82:220–6.
   PubMed Web of Science ®Google Scholar
• Rudnic EM, Lausier JM, Chilamkurti RN, Rhodes CT. (1980). Studies of the utility of cross linked polyvinylpolypyrrolidine as a tablet disintegrant. Drug Dev Ind Pharm, 6:291–309.
   Web of Science ®Google Scholar
• Schiermeier S, Schmidt PC. (2002). Fast dispersible ibuprofen tablets. Eur J Pharm Sci, 15(3):295–305.
   PubMed Web of Science ®Google Scholar
• Fielden KE, Newton JM, O'Brien P, Rowe RC. (1988). Thermal studies of the interaction of water and microcrystalline cellulose. J Pharm Pharmacol, 40:674–8.
   PubMed Web of Science ®Google Scholar
• Coviello T, Matricardi P, Marianecci C, Alhaique F. (2007). Polysaccharide hydrogels for modified release formulations. J Control Release, 119:5–24.
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Weller PJ. (2003). Carrageenan. In: Handbook of pharmaceutical excipients. 4th ed. Washington, DC: Pharmaceutical Press, 101–3.
   Google Scholar
• USP 29. (2005). Carrageenan. The United States Pharmacopoeia, The United States Pharmacopoeial Convention, 3303–4.
   Google Scholar
• Bubnis W, O'Hare K, Reilly WA. (1997). Low moisture hydrocolloid soft chewable gel delivery system. Pharm Res, 14(11):525.
   Google Scholar
• Cuzzocrea S, Mazzon E, Sautebin L. (2002). Protective effects of Celecoxib on lung injury and red blood cells modification induced by carrageenan in the rat. Biochem Pharmacol, 63(4):785–95.
   PubMed Web of Science ®Google Scholar
• Manni L, Lundeberg T, Tirassa P, Aloe L. (2002). Role of cholecystokinin-8 in nerve growth factor and nerve growth factor in mRNA expression in carrageenan-induced joint inflammation in adult rats. Rheumatology (Oxford), 41(7):787–92.
   PubMed Web of Science ®Google Scholar
• Bornhoft M, Thommes M, Kleinebudde P. (2005). Preliminary assessment of carrageenan as excipient for extrusion/spheronization. Eur J Pharm Biopharm, 59:127–31.
   PubMed Web of Science ®Google Scholar
• Thommes M, Blaschek W, Kleinebudde P. (2007). Effect of drying on extruded pellets based on ĸ–carrageenan. Eur J Pharm Sci, 31:112–18.
   PubMed Web of Science ®Google Scholar
• Thommes M, Kleinebudde P. (2006). Use of ĸ-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronization. I. Influence of type and fraction of filler. Eur J Pharm Biopharm, 63:59–67.
   PubMed Web of Science ®Google Scholar
• Thommes M, Kleinebudde P. (2006). Use of ĸ-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronization. II. Influence of drug and filler type. Eur J Pharm Biopharm, 63:68–75.
   PubMed Web of Science ®Google Scholar
• USP 29. (2005). Pectin. The United States Pharmacopoeia, The United States Pharmacopoeial Convention, 1647–8.
   Google Scholar
• Itoh K, Kubo W, Fujiwara M, Hirayama T, Miyazaki S, Dairaku M, . (2006). The influence of variation of gastric pH on the gelation and release characteristics of in situ gelling pectin formulations. Int J Pharm, 312:37–42.
   PubMed Web of Science ®Google Scholar
• Itoh K, Kubo W, Fujiwara M, Watanabe H, Miyazaki S, Attwood D. (2006). The influence of gastric acidity and taste masking agent on in situ gelling pectin formulations for oral sustained delivery of acetaminophen. Biol Pharm Bull, 29:343–47.
   PubMed Web of Science ®Google Scholar
• Kubo W, Itoh K, Miyazaki S, Attwood D. (2005). Oral sustained delivery of theophylline and cimetidine from in situ gelling pectin formulations in rabbits. Drug Dev Ind Pharm, 31:819–25.
   PubMed Web of Science ®Google Scholar
• Hiorth M, Versland T, Heikkilae J, Tho I, Sande SA. (2006). Immersion coating of pellets with calcium pectinate and chitosan. Int J Pharm, 308:25–32.
   PubMed Web of Science ®Google Scholar
• Pillay V, Danckwerts MP, Fassihi R. (2002). A crosslinked calcium-alginate–pectinate–cellulose acetophthalate gelisphere system for linear drug release. Drug Deliv, 9(2):77–86.
   PubMed Web of Science ®Google Scholar
• Aydin Z, Akbuga J. (1996). Preparation and evaluation of pectin beads. Int J Pharm, 137:133–6.
   Web of Science ®Google Scholar
• Chambin O, Dupuis G, Champion D, Voilley A, Pourcelot Y. (2006). Colon specific drug delivery: Influence of solution reticulation properties upon pectin bead performance. Int J Pharm, 321:86–93.
   PubMed Web of Science ®Google Scholar
• Tho I, Sande SA, Kleinebudde P. (2002). Pectinic acid, a novel excipient for production of pellets by extrusion/spheronization: Preliminary studies. Eur J Pharm Biopharm, 54:95–9.
   PubMed Web of Science ®Google Scholar
• Tho I, Sande SA, Kleinebudde P. (2003). Disintegrating pellets from a water-insoluble pectin derivative produced by extrusion/spheronization. Eur J Pharm Biopharm, 56:371–80.
   PubMed Web of Science ®Google Scholar
• Tho T, Kleinebudde P, Sande SA. (2001). Extrusion/spheronization of pectin-based formulations. I. Screening of important factors. AAPS PharmSciTech, 2(4):26.
   PubMedGoogle Scholar
• Rowe RC, Sheskey PJ, Weller PJ. (2003). Hypromellose. In: Handbook of pharmaceutical excipients, 4th ed. Washington, DC: Pharmaceutical Press, 297–300.
   Google Scholar
• Hardy JG, Kennerley JW, Taylor MJ. (1982). Release rates from sustained release buccal tablets in man. J Pharm Pharmacol, 34 (Suppl.):91P.
   Google Scholar
• Hogan JE. (1989). Hydroxypropylmethylcellulose sustained release technology. Drug Dev Ind Pharm, 15:975–99.
   Web of Science ®Google Scholar
• Shah AC, Britten NJ, Olanoff LS, Badalamenti JN. (1989). Gel-matrix systems exhibiting bimodal controlled release for oral delivery. J Control Release, 9:169–75.
   Web of Science ®Google Scholar
• Wilson HC, Cuff GW. (1989). Sustained release of isomazole from matrix tablets administered to dogs. J Pharm Sci, 78:582–4.
   PubMed Web of Science ®Google Scholar
• Dahl TC, Calderwood T, Bormeth A. (1990). Influence of physicochemical properties of hydroxypropylmethylcellulose on naproxen release from sustained release matrix tablets. J Control Release, 14:1–10.
   Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Weller PJ. (2003). Hydroxy ethylcellulose. In: Handbook of pharmaceutical excipients, 4th ed. Washington, DC: Pharmaceutical Press, 283–6.
   Google Scholar
• Kovacs B, Merenyi G. (1990). Evaluation of tack behaviour of coating solutions. Drug Dev Ind Pharm, 16(15):2302–23.
   Google Scholar
• Chatlapalli R, Rohera BD. (1998). Physical characterization of HPMC and HEC and investigation of their use as pelletisation aids. Int J Pharm, 161:179–93.
   Web of Science ®Google Scholar
• USP 29. (2005). Polyethylene oxide. The United States Pharmacopoeia, The United States Pharmacopoeial Convention, 3398–9.
   Google Scholar
• DOW chemical company, Technical profile, Poly (ethyleneoxide).
   Google Scholar
• Cappello B, Rosa GD, Giannini L, Rotonda MIL, Mensitieri G, Miro A, . (2006). Cyclodextrin-containing poly (ethyleneoxide) tablets for the delivery of poorly soluble drugs: Potential as buccal delivery system. Int J Pharm, 319:63–70.
   PubMed Web of Science ®Google Scholar
• El-Malah Y, Nazzal S. (2006). Hydrophilic matrices: Application of Placket-Burman screening design to model the effect of POLYOX— carbopol blends on drug release. Int J Pharm, 309:163–70.
   PubMed Web of Science ®Google Scholar
• Shenoy DB, Amiji MM. (2005). Poly (ethyleneoxide) modified poly (ϵ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm, 293:261–70.
   PubMed Web of Science ®Google Scholar
• Efentakis M, Koligliati S, Vlachou M. (2006). Design and evaluation of dry coated drug delivery system with an impermeable cup, swellable top layer and pulsatile release. Int J Pharm, 311:147–56.
   PubMed Web of Science ®Google Scholar
• Chien TY, Nuessle NO. (1985). Factors influencing migration during spheronisation. Pharm Technol, 9:42–6.
   Google Scholar
• Howard MA, Neau SH, Sack MJ. (2006). PEO and MPEG in high drug load extruded and spheronised beads that are devoid of MCC. Int J Pharm, 307:66–76.
   PubMed Web of Science ®Google Scholar
• Rama M, Saripella KK, Neau SH. (2010). Use of coarse ethylcellulose and PEO in beads produced by extrusion–spheronization. Int J Pharm, 385:53–65.
   Google Scholar
• Junnila R, Palviainen P, Heinämäki J, Myllärinen P, Forssell P, Yliruusi J. (2000). Waxy corn starch: A potent cofiller in pellets produced by extrusion-spheronization. Pharm Dev Technol, 5:67–76.
   PubMed Web of Science ®Google Scholar
• Almeida S, Prieto J, Mendez B, Espinar O. (2005). Starch – dextrin mixtures as base excipients for extrusion-spheronization pellets. Eur J Pharm Biopharm, 59:511–21.
   PubMed Web of Science ®Google Scholar
• Dukic A, Mens R, Adriaensens P, Foreman P, Gelan J, Remon JP, . (2007). Development of starch-based pellets via extrusion/spheronization. Eur J Pharm Biopharm, 66:83–94.
   PubMed Web of Science ®Google Scholar
• Chui CW, Henley M, Paul A. (1994). Process for making amylase resistant starch from high amylose starch. US patent no. 5281276, January 25.
   Google Scholar
• Dukic A, Remon JP, Foreman P, Vervaet C. (2007). Immediate release of poorly soluble drugs from starch based pellets prepared via extrusion/spheronisation. Eur J Pharm Biopharm, 67:715–24.
   PubMed Web of Science ®Google Scholar
• Dukic A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C. (2008). In-vitro and in-vivo evaluation of enteric coated starch based pellets prepared via extrusion/spheronization. Eur J Pharm Biopharm, 70:302–12.
   PubMed Web of Science ®Google Scholar
• Levis SR, Deasy PB. (2001). Pharmaceutical applications of size reduced grades of surfactant co-processed microcrystalline cellulose. Int J Pharm, 230:25–33.
   PubMed Web of Science ®Google Scholar
• Levis SR, Deasy PB. (2001). Production and evaluation of size reduced grades of microcrystalline cellulose. Int J Pharm, 213:13–24.
   PubMedGoogle Scholar
• Podczeck F, Knight PE, Newton JM. (2008). The evaluation of modified microcrystalline cellulose for the preparation of pellets with high drug loading by extrusion/spheronization. Int J Pharm, 350:145–54.
   PubMed Web of Science ®Google Scholar
• Lindner H, Kleinebudde P. (1994). Use of powdered cellulose for the production of pellets by extrusion/spheronization. J Pharm Pharmacol, 46:2–7.
   PubMed Web of Science ®Google Scholar
• Alvarez L, Concheiro A, Gomez-Amoza JL, Souto C, Martinez-Pacheco R. (2003). Powered cellulose as excipient for extrusion–spheronization pellets of a cohesive hydrophobic drug. Eur J Pharm Biopharm, 55:291–5.
   PubMed Web of Science ®Google Scholar
• El Saleh F, Jumma M, Hassan I, Kleinebudde P. (2000). Influence of cellulose type on the properties of extruded pellets. Part II. Production and properties of pellets. STP Pharm Sci, 10:379–85.
   Google Scholar
• Fechner PM, Wartewig S, Futing M, Heilmann A, Neubert RHH, Kleinebudde P. (2003). Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studies by fourier transform Raman spectroscopy and environmental scanning electron microscopy. AAPS PharmSciTech, 5(4), article 31.
   Google Scholar
• Newton JM, Boutel S, Chatchawalsaisin J, Podczeck F. (2004). The preparation of spherical granules by extrusion/spheronization without microcrystalline cellulose. Pharm Technol Eur, 16(10):21–5.
   Google Scholar
• Chatchawalsaisin J, Podczeck F, Newton JM. (2005). The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate. Eur J Pharm Sci, 24:35–48.
   PubMed Web of Science ®Google Scholar
• Montousse C, Pruvost M, Rodriguez F, Brossard C. (1999). Extrusion–spheronization manufacture of Gelucire® matrix beads. Drug Dev Ind Pharm, 25(1):75–80.
   PubMed Web of Science ®Google Scholar
• Dupont G, Flament MP, Leterme P, Farah N, Gayot A. (2002). Developing a study method for producing 400 μm spheroids. Int J Pharm, 247:159–65.
   PubMed Web of Science ®Google Scholar
• Flament MP, Dupont G, Leterme P, Farah N, Gayot A. (2004). Development of 400 μm pellets by extrusion–spheronization: Application with Gelucire® 50/02 to produce a sprinkle form. Drug Dev Ind Pharm, 30(1):43–51.
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Weller PJ. (2003). Chitosan. In: Handbook of pharmaceutical excipients. 4th ed. Washington, DC: Pharmaceutical Press, 132–5.
   Google Scholar
• Yomota C, Miyazaki T, Okada S. (1994). Sustained-release effect of the direct compressed tablet based on chitosan and Na alginate. Yakugaku Zasshi, 114:257–63.
   PubMed Web of Science ®Google Scholar
• Errington N, Harding SE, Varum KM, Illum L. (1993). Hydrodynamic characterization of chitosans varying in degree of acetylation. Int J Biol Macromol, 15:113–7.
   PubMed Web of Science ®Google Scholar
• He P, Davis SS, Illum L. (1999). Chitosan microspheres prepared by spray drying. Int J Pharm, 187:53–65.
   PubMed Web of Science ®Google Scholar
• Hejazi R, Amiji M. (2002). Stomach-specific anti-H. Pylori therapy. I: Preparation and characterisation of tetracycline-loaded chitosan microspheres. Int J Pharm, 235:87–94.
   PubMed Web of Science ®Google Scholar
• Sakkinen M, Seppala U, Heinanen P, Marvola M. (2002). In vitro evaluation of microcrystalline chitosan as gel-forming excipient in matrix granules. Eur J Pharm Biopharm, 54:33–40.
   PubMed Web of Science ®Google Scholar
• Berthold A, Cremer K, Kreuter J. (1996). Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J Control Release, 39:17–25.
   Web of Science ®Google Scholar
• Hoffmann HR, Asmussen B, Schnellzer F. (1999). Pellets auf der Basis von Chitosan. Patent DE 199/40795 A1.
   Google Scholar
• Tapia C, Buckton G, Newton JM. (1993). Factors influencing the mechanism of release from sustained release matrix pellets, produced by extrusion/spheronisation. Int J Pharm, 92:211–8.
   Web of Science ®Google Scholar
• Steckel H, Mindermann-Nogly F. (2004). Production of chitosan pellets by extrusion/spheronisation. Eur J Pharm Biopharm, 57:107–14.
   PubMed Web of Science ®Google Scholar
• Chatchawalsaisin J, Podczeck F, Newton JM. (2004). The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation. Int J Pharm, 275:41–60.
   PubMed Web of Science ®Google Scholar
• Santos H, Veiga F, Pina M, Podczeck F, Sausa J. (2002). Physical properties of chitosan pellets produced by extrusion–spheronisation: Influence of formulation variables. Int J Pharm, 246:153–69.
   PubMed Web of Science ®Google Scholar
• Agrawal AM, Manek RV, Kolling WM, Neau SH. (2004). Water distribution studies within microcrystalline cellulose and chitosan using differential scanning calorimetry and dynamic vapour sorption analysis. J Pharm Sci, 93(7):1766–79.
   PubMed Web of Science ®Google Scholar
• Agrawal AM, Howard MA, Neau SH. (2004). Extruded and spheronized beads containing no microcrystalline cellulose: Influence of formulation and process variables. Pharm Dev Technol, 9(2):197–217.
   PubMed Web of Science ®Google Scholar
• Charoenthai N, Kleinebudde P, Puttipipatkhachorn S. (2007). Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose. AAPS PharmSciTech, 8(3), article 64.
   PubMed Web of Science ®Google Scholar
• Jess K, Steckel H. (2007). The extrusion spheronization of chitosan. Pharm Technol Eur, 19(7):21–8.
   Google Scholar
• Charoenthai N, Kleinebudde P, Puttipipatkhachorn S. (2007). Use of chitosan-alginate as alternate pelletization aid to microcrystalline cellulose in extrusion/spheronization. J Pharm Sci, 96(9):2469–84.
   PubMed Web of Science ®Google Scholar
• Clare K. (1993). Algin. In: Whistler RS, BeMiller JN, eds. Industrial gums. New York: Academic Press, 105–43.
   Google Scholar
• Grant GT, Morris ER, Rees DA, Smith PJ, Thom D. (1973). Biological interaction between polysaccharides and divalent cations: The egg-box model. FEBS Lett, 32:195–8.
   Web of Science ®Google Scholar
• Sriamornsak P, Nunthanid J, Luangtana-Anan M, Puttipipatkhachorn S. (2007). Alginates based pellets prepared by extrusion/spheronisation: A preliminary study on the effect of additive in granulating liquid. Eur J Pharm Biopharm, 67:227–35.
   PubMed Web of Science ®Google Scholar
• Sriamornsak P, Nunthanid J, Luangtana-Anan M, Weerapol Y, Puttipipatkhachorn S. (2008). Alginates based pellets prepared by extrusion/spheronization: Effect of the amount and type of sodium alginate and calcium salts. Eur J Pharm Biopharm, 69:274–84.
   PubMed Web of Science ®Google Scholar
• Challa R, Ahuja A, Ali J, Khar RK. (2005). Cyclodextrin in drug delviery: An updated review. AAPS PharmSciTech, 6(2), article 43.
   PubMed Web of Science ®Google Scholar
• Szejtli J. (1991). Cyclodextrin in drug formulations: Part I. Pharm Technol Int, 3:15–23.
   Google Scholar
• Villar-López ME, Nieto-Reyes L, Anguiano-Igea S, Otero-Espinar FJ, Blanco-Méndez J. (1999). Formulation of triamcinolone acetonide pellets suitable for coating and colon targeting. Int J Pharm, 179:229–35.
   PubMed Web of Science ®Google Scholar
• Gainotti A, Bettini R, Gazzaniga A, Colombo P, Giordano F. (2004). Drug β-cyclodextrin containing pellets prepared with high shear mixer granulator. Drug Dev Ind Pharm, 30:1061–8.
   PubMed Web of Science ®Google Scholar